These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 17909206

  • 1. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.
    Alvaro D, Macarri G, Mancino MG, Marzioni M, Bragazzi M, Onori P, Corradini SG, Invernizzi P, Franchitto A, Attili AF, Gaudio E, Benedetti A.
    Ann Intern Med; 2007 Oct 02; 147(7):451-9. PubMed ID: 17909206
    [Abstract] [Full Text] [Related]

  • 2. Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions.
    Abdel-Razik A, ElMahdy Y, Hanafy EE, Elhelaly R, Elzehery R, M Tawfik A, Eldars W.
    Am J Med Sci; 2016 Mar 02; 351(3):259-64. PubMed ID: 26992254
    [Abstract] [Full Text] [Related]

  • 3. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
    Ince AT, Yıldız K, Baysal B, Danalıoğlu A, Kocaman O, Tozlu M, Gangarapu V, Sarbay Kemik A, Uysal Ö, Şentürk H.
    Turk J Gastroenterol; 2014 Apr 02; 25(2):162-9. PubMed ID: 25003676
    [Abstract] [Full Text] [Related]

  • 4. Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses.
    Severino V, Dumonceau JM, Delhaye M, Moll S, Annessi-Ramseyer I, Robin X, Frossard JL, Farina A.
    Gastroenterology; 2017 Aug 02; 153(2):495-504.e8. PubMed ID: 28479376
    [Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study.
    Navaneethan U, Gutierrez NG, Jegadeesan R, Venkatesh PG, Poptic E, Liu X, Sanaka MR, Jang S, Vargo JJ, Parsi MA.
    Dig Dis Sci; 2013 Oct 02; 58(10):2986-92. PubMed ID: 23828141
    [Abstract] [Full Text] [Related]

  • 6. EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study.
    Weilert F, Bhat YM, Binmoeller KF, Kane S, Jaffee IM, Shaw RE, Cameron R, Hashimoto Y, Shah JN.
    Gastrointest Endosc; 2014 Jul 02; 80(1):97-104. PubMed ID: 24559784
    [Abstract] [Full Text] [Related]

  • 7. Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video).
    Navaneethan U, Hasan MK, Kommaraju K, Zhu X, Hebert-Magee S, Hawes RH, Vargo JJ, Varadarajulu S, Parsi MA.
    Gastrointest Endosc; 2016 Oct 02; 84(4):649-55. PubMed ID: 26995690
    [Abstract] [Full Text] [Related]

  • 8. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
    Leelawat K, Sakchinabut S, Narong S, Wannaprasert J.
    BMC Gastroenterol; 2009 Apr 30; 9():30. PubMed ID: 19405942
    [Abstract] [Full Text] [Related]

  • 9. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
    Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA.
    Am J Surg; 1996 Jan 30; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
    [Abstract] [Full Text] [Related]

  • 10. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
    Chen WM, Wei KL, Chen YS, Chang PJ, Tung SY, Chang TS, Huang HC, Shen CH, Hsieh YY, Wu CS.
    World J Surg Oncol; 2016 May 04; 14():140. PubMed ID: 27142076
    [Abstract] [Full Text] [Related]

  • 11. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study.
    Navaneethan U, Parsi MA, Lourdusamy V, Bhatt A, Gutierrez NG, Grove D, Sanaka MR, Hammel JP, Stevens T, Vargo JJ, Dweik RA.
    Gastrointest Endosc; 2015 Apr 04; 81(4):943-9.e1. PubMed ID: 25500329
    [Abstract] [Full Text] [Related]

  • 12. Triple-tissue sampling during endoscopic retrograde cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma.
    Lee SJ, Lee YS, Lee MG, Lee SH, Shin E, Hwang JH.
    Gut Liver; 2014 Nov 04; 8(6):669-73. PubMed ID: 25368755
    [Abstract] [Full Text] [Related]

  • 13. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
    Farina A, Dumonceau JM, Antinori P, Annessi-Ramseyer I, Frossard JL, Hochstrasser DF, Delhaye M, Lescuyer P.
    Biochim Biophys Acta; 2014 May 04; 1844(5):1018-25. PubMed ID: 23806607
    [Abstract] [Full Text] [Related]

  • 14. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
    Zabron AA, Horneffer-van der Sluis VM, Wadsworth CA, Laird F, Gierula M, Thillainayagam AV, Vlavianos P, Westaby D, Taylor-Robinson SD, Edwards RJ, Khan SA.
    Am J Gastroenterol; 2011 Sep 04; 106(9):1711-7. PubMed ID: 21670771
    [Abstract] [Full Text] [Related]

  • 15. Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction.
    Beyazıt Y, Koçak E, Tanoğlu A.
    Turk J Gastroenterol; 2014 Oct 04; 25(5):592-3. PubMed ID: 25417631
    [No Abstract] [Full Text] [Related]

  • 16. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
    Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, Lee JH, Kim KA, Kim AY, Kim PN, Lee MG, Ha HK.
    Radiology; 2004 Oct 04; 233(1):234-40. PubMed ID: 15333766
    [Abstract] [Full Text] [Related]

  • 17. The value of biliary fibronectin for diagnosis of cholangiocarcinoma.
    Chen CY, Lin XZ, Tsao HC, Shiesh SC.
    Hepatogastroenterology; 2003 Oct 04; 50(52):924-7. PubMed ID: 12845951
    [Abstract] [Full Text] [Related]

  • 18. MR cholangiopancreatography in malignant biliary obstruction.
    Pavone P, Laghi A, Passariello R.
    Semin Ultrasound CT MR; 1999 Oct 04; 20(5):317-23. PubMed ID: 10527137
    [Abstract] [Full Text] [Related]

  • 19. Serum and bile biomarkers for cholangiocarcinoma.
    Alvaro D.
    Curr Opin Gastroenterol; 2009 May 04; 25(3):279-84. PubMed ID: 19396965
    [Abstract] [Full Text] [Related]

  • 20. Imaging techniques in patients with biliary obstruction.
    Cieszanowski A, Chomicka D, Andrzejewska M, Pruszyński B, Pawlak J, Mustafa AM.
    Med Sci Monit; 2000 May 04; 6(6):1197-202. PubMed ID: 11208479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.